Prognostic significance of differentially expressed miRNAs in esophageal cancer

International Journal of Cancer

Volumn 128, Issue 1, 2011, Pages 132-143

  Hu, Yuxin ^a   Correa, Arlene M ^b   Hoque, Ashraful ^a   Guan, Baoxiang ^a   Ye, Fei ^a   Huang, Jie ^a   Swisher, Stephen G ^b   Wu, Tsung Teh ^c   Ajani, Jaffer A ^b   Xu, Xiao Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Cell viability; Esophageal cancer; Gene regulation; MiRNA; Prognosis

Indexed keywords

CYCLIN D1; MICRORNA;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NORTHERN BLOTTING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; SQUAMOUS CELL CARCINOMA; TRANSIENT TRANSFECTION; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS;

EID: 78349253777     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25330     Document Type: Article

References (42)

1. Blot W,. Esophageal cancer trends and risk factors. Semin Oncol 1994; 21: 403 10.
2. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ,. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005; 54: 1062 6.
3. Chen X, Yang CS,. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001; 22: 1119 29.
4. Reid BJ, Blount PL, Rabinovitch PS,. Biomarkers in Barrett's esophagus. Gastrointest Endosc Clin N Am 2003; 13: 369 97.
5. Spechler SJ,. Barrett's esophagus: a molecular perspective. Curr Gastroenterol Rep 2005; 7: 177 81.
6. Mandard AM, Hainaut P, Hollstein M,. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000; 462: 335 42.
7. Montesano R, Hollstein M, Hainaut P,. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996; 69: 225 35.
8. Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC,. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2005; 14: 2481 6.
9. McManus DT, Olaru A, Meltzer SJ,. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res 2004; 64: 1561 9.
10. Xu X-C,. Risk factors and altered gene expression in esophageal cancer. In:, Verma M, eds. Cancer epidemiology. New York: Humana Press, 2009. 335 60.
11. Song S, Xu X-C,. Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Comm 2001; 281: 872 7.
12. Li M, Song S, Lippman SM, Zhang XK, Liu X, Lotan R, Xu X-C,. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 2002; 21: 411 18.
13. 2 expression. Oncogene 2005; 24: 8268 76.
14. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281 97.
15. Alvarez-Garcia I, Miska EA,. MicroRNA functions in animal development and human disease. Development 2005; 132: 4653 62.
16. Gregory RI, Shiekhattar R,. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509 12.
17. McManus MT,. MicroRNAs and cancer. Semin Cancer Biol 2003; 13: 253 8.
18. Croce CM, Calin GA,. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6 7.
19. Mendell JT,. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005; 4: 1179 84.
20. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524 9.
21. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ,. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882 91.
22. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T,. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753 6.
23. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A,. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39: 167 9.
24. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE,. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627 32.
25. Chan JA, Krichevsky AM, Kosik KS,. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029 33.
26. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N,. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26 33.
27. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834 8.
28. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R,. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999; 59: 2477 83.
29. Xu XC, Clifford JL, Hong WK, Lotan R,. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry. Diagn Mol Pathol 1994; 3: 122 31.
30. 2 on tumor cell growth and gene expression through binding to and inhibiting RhoA. Cancer Res 2006; 66: 7111 18.
31. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT,. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 2006; 12: 4598 604.
32. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen S, Plasterk RH,. MicroRNA expression in zebrafish embryonic development. Science 2005; 309: 310 11.
33. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130 4.
34. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745 52.
35. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M, Baba H,. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915 22.
36. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192 200.
37. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM,. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901 8.
38. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Cali GA, Liu CG, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189 98.
39. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257 61.
40. Aqeilan RI, Calin GA, Croce CM,. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Diffn 2010; 17: 215 20.
41. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM,. MicroRNA signatures in human ovarian cancer. Cancer Res 2007; 67: 8699 707.
42. Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, Mutch DG, Grigsby PW, Powell SN, Wang X,. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol 2009; 114: 457 64.